2021
DOI: 10.1016/j.bpc.2021.106628
|View full text |Cite
|
Sign up to set email alerts
|

Polymyxin B accelerates the α-synuclein aggregation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 39 publications
0
2
0
Order By: Relevance
“…During the treatment period, the number of nephrotoxicity cases in the observation group was 3 cases (6.82%), which was not significantly different from 4 cases (10.00%) in the control group. Many previous studies have reported [ 16 , 17 ] that nephrotoxicity is the most common adverse reaction in the clinical application of polymyxin B. Combined with the conclusions of this study, some differences may be related to the relatively small number of samples included in this study.…”
Section: Discussionmentioning
confidence: 68%
“…During the treatment period, the number of nephrotoxicity cases in the observation group was 3 cases (6.82%), which was not significantly different from 4 cases (10.00%) in the control group. Many previous studies have reported [ 16 , 17 ] that nephrotoxicity is the most common adverse reaction in the clinical application of polymyxin B. Combined with the conclusions of this study, some differences may be related to the relatively small number of samples included in this study.…”
Section: Discussionmentioning
confidence: 68%
“…The sonicated sample was boiled at 95 °C. The insoluble white precipitate was then pelleted at 20,000 g for 1 h. The clear supernatant was passed through a 0.45 μm filter before further purifying using chromatographic methods as described elsewhere (33).…”
Section: Methodsmentioning
confidence: 99%